FluGen Inc   Report issue

For profit Phase 1
Founded: Madison WI United States (2007)

Organization Overview

First Clinical Trial
2016
NCT02822105
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

FluGen Inc | RCA

Active Ingredients

Drugs in Phase 1 Trials (2)

bris10 (1 trial)

inactivated influenza vaccine (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 2